The 30-share index opened flat at 14,129.89 and then lost its power and started trading negatively. In the mid-noon trades, the index continued to trade in a negative zone and closed lower. Stocks from oil & gas, automobile and metal led the declines.
In contrast, Asian stocks heaved after increase in metals prices that pushed metal stocks towards the upward direction and US productivity data exhibited better-than-expected growth.
The BSE Sensex ended the day at 13,934.27, after losing 143.94 points while Nifty closed at 4,117.35, down 33.5 points.
Out of the total 2,667 shares, 1,130 boosted, 1,453 turned down while 84 remained on their previous places.

After opening sturdily at 13,987.77, the stock market continued to trade optimistically on the back of Asian market that climbed up to their weekly highs.
Then, in the afternoon trades, the stock index continued its volatility and touched a high of 14,082.26, and lastly ended on a firm note. The stocks, which led the advancements, include auto, cement and metal.
Likewise, Asian stocks mounted Thursday on profits viewpoint that advanced sureness in investors and as Korea Electric Power Corp. reported better than expected earnings. In addition, United Microelectronics Corp. also reported elevated earnings.

As per reports, approximately one-fifth of the retail turnover is being transacted online which is low as compared to markets like South Korea and Japan having 85% and 80% of the total retail turnover is transacted over the Internet. Hong Kong and Singapore market’s net-based transactions account for only 15% of the retail turnover.

Internet trading in India has grown 100% every year during the last 5 years. Almost 45% of the total retail trading is expected through the online network.

The Internet seems like the biggest leveler, enabler and differentiator as the broking industry will split into two parts where one would like to call itself wealth management providers while others will concentrate on the high volume business by providing lower charges.

Africa has been a hushed moneymaker for India’s major drug manufacturing company Ranbaxy making a